Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$70.37 USD
-0.63 (-0.89%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $70.32 -0.05 (-0.07%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 27% (69 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | 1.13 | 7.43 | 60.00 |
Year Ago Quarter Estimate | 2.28 | 0.12 | 52.54 |
Next Quarter Estimate | 1.11 | 7.81 | 61.00 |
Next Year Estimate | 5.27 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 12.32 | 12.90 | 17.08 |
Next Year | 15.57 | 8.30 | 8.00 |
Last 5 Years | -4.50 | 1.00 | 8.10 |
Next 5 Years | NA | 19.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 12.31 | -2.18 |
Price/Book (MRQ) | 1.76 | 2.01 |
Price/Cash Flow (MRFY) | 14.19 | 14.08 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 37.80% | -100.99% |
Return on Equity (TTM) | 11.98% | -55.59% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.